Research compound supplied in Australia by Pulse Biolabs for laboratory use. Available in 10mg.
Adamax is described as Semax with an adamantane group attached. The Semax literature is real. A literature for Adamax itself was not found for this note.
Adamax is described as Semax, a seven-amino-acid peptide derived from part of ACTH, with an adamantane group attached; the exact structure of material sold under this name has not been independently confirmed. Semax is studied for its effect on nerve-supporting signals such as BDNF, mainly in rats. For Adamax itself, no peer-reviewed cell, animal or human study was identified in preparing this note, so nothing from the parent literature can be assumed to apply.
Read the full research note →| Presentation | Code | Status | Price |
|---|---|---|---|
| 10mg | ADX10 | In stock | $110 |
No batch-specific test report is currently published for this product. What a report does and does not show.
Supplied as lyophilised (freeze-dried) powder in a sealed vial. Store sealed and protected from light at the conditions stated on the product label or supplied specification. Solvent choice, concentration and handling after reconstitution depend on the compound and on the laboratory’s own procedures, and are not specified here.
No approved medicine containing Adamax was identified in Australia or any other jurisdiction, and no published clinical study of it was found. The parent compound Semax is used clinically in Russia (see note 008); nothing about that use extends to a modified derivative.
Status checked 2026-09-23. Details and sources in the research note.